Extendicare (TSE:EXE – Get Free Report) is scheduled to issue its quarterly earnings data after the market closes on Wednesday, May 15th.
Extendicare (TSE:EXE – Get Free Report) last posted its quarterly earnings results on Thursday, March 7th. The company reported C$0.10 earnings per share (EPS) for the quarter. The firm had revenue of C$350.18 million during the quarter. Extendicare had a net margin of 2.60% and a return on equity of 36.03%.
Extendicare Trading Down 1.1 %
TSE EXE opened at C$7.43 on Wednesday. The stock has a market capitalization of C$617.88 million, a P/E ratio of 18.58 and a beta of 1.22. Extendicare has a 52-week low of C$5.75 and a 52-week high of C$7.90. The firm has a 50-day moving average price of C$7.33 and a 200 day moving average price of C$7.02. The company has a quick ratio of 0.98, a current ratio of 0.83 and a debt-to-equity ratio of 380.48.
Extendicare Dividend Announcement
Analysts Set New Price Targets
EXE has been the subject of several analyst reports. Leede Jones Gable increased their price target on shares of Extendicare from C$7.00 to C$8.50 and gave the stock a “buy” rating in a report on Monday, March 11th. TD Securities increased their price target on shares of Extendicare from C$7.00 to C$7.50 and gave the stock a “hold” rating in a report on Monday, March 11th. Finally, Royal Bank of Canada increased their target price on shares of Extendicare from C$7.50 to C$8.00 and gave the company a “sector perform” rating in a report on Monday, March 11th. Three investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to data from MarketBeat, the stock currently has an average rating of “Hold” and an average target price of C$7.88.
Get Our Latest Stock Analysis on Extendicare
Extendicare Company Profile
Extendicare Inc, through its subsidiaries, provides care and services for seniors in Canada. The company offers long term care (LTC) services; and home health care services, such as nursing care, occupational, physical and speech therapy, and assistance with daily activities, as well as management, consulting, and other services to third parties.
Recommended Stories
- Five stocks we like better than Extendicare
- What Are Dividend Challengers?
- Garmin Navigates to New Highs Driven By Wearables Trend
- Airline Stocks – Top Airline Stocks to Buy Now
- Pinterest Prospers From AI Boosting Shop-Ability and Relevance
- What is the Nikkei 225 index?
- AbbVie Tracking for New Highs in 2024
Receive News & Ratings for Extendicare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Extendicare and related companies with MarketBeat.com's FREE daily email newsletter.